Australian newspaper The Age reports in “Broken leg bones healed in stem cell first” that a trial for new stem cell therapy has produced some remarkable results in healing the most serious kinds of fractures. The trial included nine patients with severe leg fractures, many unable to walk and spending up to 41 months waiting for bones to heal.
The therapy involves taking bone marrow stem cells from the patients pelvis and culturing them in a test tube. The stem cells are then applied to fracture sites, where they spur rapid growth of new bone. The average result in the trial was a four-month recovery time. The therapy is expected to halve healing time for less severe breaks.
The therapy is owned by regenerative medicine company Mesoblast. Earlier trials were performed in the UK and the therapy is expected to be generally available in 3-5 years.